HomeFMS • NYSE
Fresenius Medical Care AG
$22.27
Jan 13, 9:31:19 AM GMT-5 · USD · NYSE · Disclaimer
US listed security
Previous close
$22.49
Day range
$22.25 - $22.27
Year range
$17.93 - $24.31
Market cap
13.11B USD
Avg Volume
246.90K
CDP Climate Change Score
C
Market news
Financials
Income Statement
Revenue
Net income
(EUR)Sep 2024Y/Y change
Revenue
4.76B-3.57%
Operating expense
750.20M-13.23%
Net income
213.03M152.55%
Net profit margin
4.48161.99%
Earnings per share
0.82187.72%
EBITDA
761.73M1.44%
Effective tax rate
30.62%—
Total assets
Total liabilities
(EUR)Sep 2024Y/Y change
Cash and short-term investments
1.37B-11.74%
Total assets
32.51B-8.77%
Total liabilities
17.72B-12.28%
Total equity
14.79B—
Shares outstanding
293.41M—
Price to book
0.48—
Return on assets
2.98%—
Return on capital
3.74%—
Net change in cash
(EUR)Sep 2024Y/Y change
Net income
213.03M152.55%
Cash from operations
984.71M29.61%
Cash from investing
-219.93M-45.55%
Cash from financing
-477.08M-15.70%
Net change in cash
275.33M29.23%
Free cash flow
1.00B313.51%
About
Fresenius Medical Care AG & Co. KGaA is a German healthcare company which provides kidney dialysis services through a network of 4,171 outpatient dialysis centers, serving 345,425 patients. The company primarily treats end-stage renal disease, which requires patients to undergo dialysis 3 times per week for the rest of their lives. With a global headquarters in Bad Homburg vor der Höhe, Germany, and a North American headquarters in Waltham, Massachusetts, it has a 38% market share of the dialysis market in the United States. It also operates 42 production sites, the largest of which are in the U.S., Germany, and Japan. The company is 32% owned by Fresenius and, as of 2020, generates around 50% of the group's revenue. The company is on the Best Employers List published by Forbes. Wikipedia
Founded
1996
Employees
113,079
Search
Clear search
Close search
Google apps
Main menu